Quick Answer
Ginkgo Bioworks Holdings, Inc. reported Stockholders Equity of $508.59 million for fiscal year 2025.
Ginkgo Bioworks Holdings, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $508.59M | -29.0% |
| 2024 | $716.06M | -34.7% |
| 2023 | $1.10B | -36.8% |
| 2022 | $1.74B | +15.3% |
| 2021 | $1.51B | +226.3% |
| 2020 | $461.38M | -8.1% |
| 2019 | $501.85M | +135.1% |
| 2018 | $213.43M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $559.78M | -29.8% | -8.7% |
| June 30, 2025 | $612.95M | -26.4% | -5.3% |
| March 31, 2025 | $647.43M | -34.4% | -9.6% |
| December 31, 2024 | $716.06M | -34.7% | -10.3% |
| September 30, 2024 | $797.94M | -36.3% | -4.2% |
| June 30, 2024 | $833.07M | -44.6% | -15.6% |
| March 31, 2024 | $987.27M | -38.6% | -10.0% |
| December 31, 2023 | $1.10B | -36.8% | -12.4% |
- Ginkgo Bioworks Holdings, Inc. showed a decrease of -29.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, Ginkgo Bioworks Holdings, Inc.’s stockholders equity has grown by 138.3% (from $213.43 million to $508.59 million).
- The most recent figure is from Ginkgo Bioworks Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: